We’re covering Asia-Pacific approaches to Omicron and progress in India’s ambitious water-access plan.

countries in Asia are all over the map with their containment approaches.

Heightening the urgency, data shows that Asia’s most widely used vaccines — including those made by AstraZeneca, Sinovac and Sinopharm — show no ability to stop Omicron infections six months after vaccination. (Most vaccines still seem to provide a significant degree of protection against serious illness from Omicron.)

New Zealand said on Tuesday that it was pushing back a phased opening of its borders to the end of February. It has detected 22 cases of Omicron in international arrivals but no community spread. In the event of an outbreak, the government intends to replace the lockdowns of the past with more targeted measures, the Covid minister said. It is also speeding up booster shots and bringing back quarantine for Kiwis returning home.

Other countries in the Asia-Pacific region are taking their own approaches.

India has not announced new rules but told governors to be on alert, as Omicron cases have multiplied quickly. Ninety percent of vaccinated people in India received the AstraZeneca vaccine, under the brand name Covishield.

Omicron has been identified. In one of the hardest-hit areas, Zhejiang province, thousands of people were placed under quarantine and some businesses

Continue reading – Article source

Posts from the same category:

    None Found